|

ioMRI in the Surgery of Brain Metastases.

RECRUITINGN/ASponsored by Technical University of Munich
Actively Recruiting
PhaseN/A
SponsorTechnical University of Munich
Started2025-01-17
Est. completion2027-01-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07197632

Summary

The study aims to improve the surgical treatment of brain metastases through the use of advanced imaging techniques. The investigators are examining how intraoperative MRI (iMRI) can aid surgeons in precisely locating and removing tumors, with the potential to enhance surgical outcomes and reduce the need for additional procedures. While iMRI offers the promise of better tumor visualization during surgery, it is also associated with longer surgical times and may carry the risk of increased complications. This study seeks to carefully evaluate these aspects to determine the overall benefits and challenges of iMRI in brain metastasis surgeries. The ultimate aim is to enhance treatment effectiveness and improve recovery and health outcomes for participants dealing with brain metastases.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients for whom surgical resection of brain metastasis is indicated

Exclusion Criteria:

* age \< 18
* 3T MRI contraindications

Conditions2

Brain MetastasesCancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.